Australia markets closed

Fate Therapeutics, Inc. (FATE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.2200+0.1000 (+3.21%)
At close: 04:00PM EDT
3.3500 +0.13 (+4.04%)
After hours: 07:47PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
12,317
63,533
96,300
55,846
31,434
-
Operating expenses
Research development
132,833
172,596
320,454
215,519
125,623
-
Selling general and administrative
74,989
81,448
84,232
57,321
33,896
-
Total operating expenses
207,822
254,044
404,686
272,840
159,519
-
Operating income or loss
-195,505
-190,511
-308,386
-216,994
-128,085
-
Interest expense
-
-
-
0
0
1,752
Total other income/expenses net
1,695
12,397
20,823
3,534
-47,702
-
Income before tax
-175,723
-160,928
-281,721
-212,151
-173,387
-
Income from continuing operations
-175,723
-160,928
-281,721
-212,151
-173,387
-
Net income
-175,723
-160,928
-281,721
-212,151
-173,387
-
Net income available to common shareholders
-175,723
-160,928
-281,721
-212,151
-173,387
-
Basic EPS
-1.77
-1.64
-2.91
-2.24
-2.10
-
Diluted EPS
-1.77
-1.64
-2.91
-2.24
-2.10
-
Basic average shares
98,064
98,411
96,826
94,747
82,385
-
Diluted average shares
98,064
98,411
96,826
94,747
82,385
-